Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Acute severe uterine bleeding

Obstetrics and gynaecology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Ongoing haemorrhage is a resuscitation problem

Shock, syncope, confusion, chest pain, severe breathlessness, persistent flooding, peritonism or a rapidly worsening patient requires immediate major-haemorrhage and senior gynaecology action.

Action: Use ABCDE, call for senior and anaesthetic help, obtain large-bore access, warm the patient, send urgent bloods and crossmatch, activate the local haemorrhage protocol when indicated and pursue definitive bleeding control in parallel.

Synopsis

Recognise dangerous uterine bleeding, resuscitate while excluding pregnancy and extrauterine sources, use haemostatic medicines safely in stable patients, and escalate without delay to tamponade, radiology or surgery when bleeding continues.

  • Estimate physiological severity before counting pads: observations, consciousness, perfusion, urine output, ongoing visible loss and comorbidity determine urgency.
  • Ask last normal period and obtain a consented pregnancy test early, but never delay resuscitation or theatre for an unstable suspected pregnancy haemorrhage.
  • Confirm the source with focused abdominal and consented speculum examination when stable enough; avoid digital vaginal examination in later-pregnancy bleeding until placenta praevia is addressed.
  • Obtain two large-bore cannulas, full blood count, group-and-save or crossmatch, renal and liver profile, coagulation and fibrinogen under the major-haemorrhage pathway, with venous gas and lactate when unwell.
  • Haemoglobin can remain initially normal in acute blood loss; transfusion and haemorrhage activation are driven by physiology, ongoing loss and anticipated control, not a delayed number alone.
  • For a haemodynamically stable non-pregnant patient without contraindication, tranexamic acid and an appropriate hormonal regimen can reduce bleeding while cause and definitive follow-up are arranged.
  • A licensed oral norethisterone regimen for dysfunctional uterine bleeding is 5 mg three times daily for 10 days, but exclude pregnancy and major thrombotic or hepatic contraindications before use.
  • Oral tranexamic acid for heavy menstrual bleeding is 1 g three times daily for up to four days from the onset of heavy loss; renal impairment and thrombotic history modify safety.
  • If bleeding persists or the patient is unstable, senior options include uterine tamponade, hysteroscopy with treatment, evacuation for retained tissue, uterine artery embolisation or surgery according to cause and fertility goals.
  • After control, treat iron deficiency, establish the PALM-COEIN cause, review anticoagulation collaboratively and provide a written plan for recurrence.

Key red flags

A positive or uncertain pregnancy test changes the emergency differential to ectopic pregnancy, miscarriage, retained tissue, trophoblastic or placental bleeding and requires the appropriate obstetric pathway.

Tachycardia, hypotension, narrow pulse pressure, delayed capillary refill, oliguria, altered mentation or rising lactate signals tissue hypoperfusion even before haemoglobin falls.

Severe unilateral pain, peritonism, shoulder-tip pain or collapse raises intraperitoneal bleeding and should not be managed as isolated heavy menstruation.

Fever, offensive discharge, recent uterine procedure, postpartum state or marked tenderness raises uterine infection or sepsis and requires antimicrobial and source-control planning.

Anticoagulant exposure, thrombocytopenia, liver disease or inherited bleeding disorder may amplify loss and needs urgent haematology-informed reversal or replacement without delaying local control.

Bleeding continuing despite resuscitation and appropriate medication requires immediate procedural escalation rather than repeated outpatient-dose prescriptions.

Compensated blood loss

Tachycardia, pallor, dizziness and delayed refill can precede hypotension and a haemoglobin fall, especially in a young otherwise healthy patient.

Decompensated haemorrhage

Investigation priorities

01
Serial observations and perfusionFirst step

Determine haemorrhage severity and response to resuscitation in real time.

Management branches

Unstable bleedingResuscitate and control the source in parallel

Uterine bleeding accompanies shock, hypoperfusion, ongoing flooding or rapid deterioration.

  1. Activate ABCDE, major-haemorrhage and senior gynaecology and anaesthetic support, establish large-bore access, warm the patient and send urgent crossmatched bloods.
  2. Establish pregnancy status and likely anatomical source without delaying transfer to theatre, embolisation or pregnancy-specific surgery when clinically compelling.
  3. Use blood components, tranexamic acid or reversal under the local protocol and move to mechanical or operative haemostasis if loss continues.
Stable non-pregnant bleedingUse time-limited medical haemostasis while defining cause

Bleeding is substantial but observations and perfusion remain stable and pregnancy is excluded.

  1. Obtain full blood count, group-and-save and focused examination, and review thrombosis, liver, kidney, contraceptive and medicine factors.
  2. Offer oral tranexamic acid and an appropriate hormonal regimen such as licensed norethisterone when indicated and safe, with exact duration and stop advice.
  3. Arrange timely ultrasound, hysteroscopy or specialist review and escalate immediately if flooding, pain, symptoms or physiology worsens despite treatment.

Key medicines

Tranexamic acid tabletsGive 1 g orally three times daily for up to four days, starting when heavy bleeding begins; do not exceed the product maximum and reduce the regimen in renal impairment.Avoid with active thromboembolic disease and assess important thrombotic history, haematuria and combined hormonal use; visual symptoms require cessation and urgent review. Intravenous dosing belongs to the local haemorrhage protocol.
Norethisterone tabletsGive 5 mg orally three times daily for 10 days for licensed dysfunctional uterine bleeding; explain that withdrawal bleeding usually occurs within several days after the course ends.Exclude pregnancy and avoid with current or important previous venous or arterial thrombosis, severe liver disease and unexplained malignancy-risk bleeding; it is not contraceptive and the SmPC governs interactions.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG24 blood transfusionMajor haemorrhage distinction, thresholds and transfusion safety.
  • NICE NG88 heavy menstrual bleedingHMB assessment, medicines and specialist escalation.
  • Tranexamic acid tablet SmPCLicensed oral menorrhagia regimen, contraindications and renal adjustment.
  • Norethisterone 5 mg SmPCDysfunctional uterine bleeding regimen and safety.
  • NHS heavy periodsSymptoms, urgent help and treatment overview.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom

Hypotension, confusion, oliguria, cool peripheries, collapse or rising lactate indicates inadequate perfusion and demands protocolled resuscitation and control.